Shuichiro Shiina, M.D., Ph.D.
Professor
Department of Gastroenterology, Juntendo University
The American Gastroenterological Association, Asian Pacific Association for the Study of the Liver, The International Liver Cancer Association (Founding member), The International Association of Pancreatology, Asian Conference on Tumor Ablation, The Japanese Society of Internal Medicine, The Japanese Society of Gastroenterology, The Japan Society of Hepatology, Japan Gastroenterological Endoscopy Society, The Japan Society of Ultrasonics in Medicine, The Japanese Society of Adult Diseases, The Liver Cancer Study Group of Japan, Study Group of Microwave Surgery, The Japan Society of Clinical Oncology, The Japan Pancreas Society, Japan Association of Molecular Targeted Therapy for HCC, Japan Biliary Association, Japan Radiological Society, Japanese Society of Interventional Radiology
・APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19
（Shuichiro Shiina 1, Rino A Gani 2, Osamu Yokosuka 3, Hitoshi Maruyama 4, Hiroaki Nagamatsu 4, Diana Alcantara Payawal 5, A Kadir Dokmeci 6, Laurentius A Lesmana 7, Tawesak Tanwandee 8, George Lau 9 10, Shiv Kumar Sarin 11, Masao Omata 12 13
Affiliations expand
PMID: 33174159 PMCID: PMC7655459 DOI: 10.1007/s12072-020-10103-4）
・Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation
（Koji Uchino 1, Ryosuke Tateishi 1, Ryo Nakagomi 1, Naoto Fujiwara 1, Tatsuya Minami 1, Masaya Sato 1, Kenichiro Enooku 1, Hayato Nakagawa 1, Yoshinari Asaoka 1, Yuji Kondo 1, Junji Shibahara 2, Shuichiro Shiina 3, Kazuhiko Koike 1
Affiliations expand
PMID: 30044835 PMCID: PMC6059486 DOI: 10.1371/journal.pone.0200943）
・Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy
（Mizuki Nishibatake Kinoshita 1, Tatsuya Minami 1, Ryosuke Tateishi 2, Taijiro Wake 1, Ryo Nakagomi 1, Naoto Fujiwara 1, Masaya Sato 1, Koji Uchino 1, Kenichiro Enooku 1, Hayato Nakagawa 1, Yoshinari Asaoka 1, Shuichiro Shiina 3, Kazuhiko Koike 1
Affiliations expand
PMID: 30336183 DOI: 10.1016/j.jhep.2018.09.029）
・Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
（Masao Omata 1 2, Ann-Lii Cheng 3, Norihiro Kokudo 4, Masatoshi Kudo 5, Jeong Min Lee 6, Jidong Jia 7, Ryosuke Tateishi 8, Kwang-Hyub Han 9, Yoghesh K Chawla 10, Shuichiro Shiina 11, Wasim Jafri 12, Diana Alcantara Payawal 13, Takamasa Ohki 14, Sadahisa Ogasawara 15, Pei-Jer Chen 16, Cosmas Rinaldi A Lesmana 17 18, Laurentius A Lesmana 17, Rino A Gani 18, Shuntaro Obi 19, A Kadir Dokmeci 20, Shiv Kumar Sarin 21
Affiliations expand
PMID: 28620797 PMCID: PMC5491694 DOI: 10.1007/s12072-017-9799-9）
・Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update
（Masatoshi Kudo 1, Yusuke Kawamura 2, Kiyoshi Hasegawa 3, Ryosuke Tateishi 4, Kazuya Kariyama 5, Shuichiro Shiina 6, Hidenori Toyoda 7, Yasuharu Imai 8, Atsushi Hiraoka 9, Masafumi Ikeda 10, Namiki Izumi 11, Michihisa Moriguchi 12, Sadahisa Ogasawara 13, Yasunori Minami 1, Kazuomi Ueshima 1, Takamichi Murakami 14, Shiro Miyayama 15, Osamu Nakashima 16, Hirohisa Yano 17, Michiie Sakamoto 18, Etsuro Hatano 19, Mitsuo Shimada 20, Norihiro Kokudo 21, Satoshi Mochida 22, Tetsuo Takehara 23
Affiliations expand
PMID: 34239808 PMCID: PMC8237791 DOI: 10.1159/000514174）
Specialty/ Research Field：
Interventional oncology and minimally invasive therapy, such as Radiofrequency Ablation and Microwave Ablation, Diagnosis and treatment of liver neoplasms, Chemotherapy of GI tract cancersOther Activities：
・Liver Cancer Study Group of Japan（executive director）
・Asian Conference on Tumor Ablation (Steering Committee member, Guideline Committee Chairman)
The lecture video：0
Abstract：0
45
0
0
The academic assignments are as follows
| Date (UTC+8) | Time (UTC+8) | Local Time | Room | Session | Role | Talk Title |
|---|---|---|---|---|---|---|
| 2022-09-18 | 13:45-15:15 | 2022-09-18,13:45-15:15 | Meeting Room 1 |
Concurrent Session 13 - Fatty Liver Disease II |
Moderator |